Survival of Mesenchymal Stem Cells in Different Methods of Nebulization


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We compared survival of bone marrow mesenchymal stem cells after compressor, ultrasound, and mesh nebulization of the cell suspension over 10 min. Viability of stromal cells was best preserved after compressor nebulization (72%). Cell survival after ultrasonic nebulization was significantly lower (20%). After mesh nebulization, no live cells were found. Thus, compressor nebulization is the most preferable method of the production of cell aerosol for their delivery to the lower respiratory tract.

About the authors

A. V. Aver’yanov

Research Institute of Pulmonology, Federal Biomedical Agency

Author for correspondence.
Email: averyanovav@mail.ru
Russian Federation, Moscow

A. G. Konoplyannikov

National Medical Radiology Research Center, Ministry of Health of the Russian Federation

Email: averyanovav@mail.ru
Russian Federation, Obninsk

N. S. Antonov

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow

G. L. Osipova

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow

O. S. Vasil’eva

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow

M. G. Sakharova

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow

A. R. Tatarskii

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow

V. I. Kobylyansky

Research Institute of Pulmonology, Federal Biomedical Agency

Email: averyanovav@mail.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies